{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:31:56Z","timestamp":1791851516765,"version":"4.3.4"},"reference-count":50,"publisher":"Deutscher Arzte-Verlag GmbH","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.3238\/arztebl.2018.0222","type":"journal-article","created":{"date-parts":[[2018,3,26]],"date-time":"2018-03-26T09:51:32Z","timestamp":1522057892000},"source":"Crossref","is-referenced-by-count":60,"title":["The Diagnosis and Treatment of Functional Dyspepsia"],"prefix":"10.3238","author":[{"given":"Ahmed","family":"Madisch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viola","family":"Andresen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Enck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim","family":"Labenz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Frieling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Schemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"11437","published-online":{"date-parts":[[2018,3,30]]},"reference":[{"key":"10.3238\/arztebl.2018.0222_ref1","unstructured":"Stanghellini V, Talley NJ, Chan F, et al.: Rome IV \u2013 Gastroduodenal Disorders. Gastroenterology 2016 pii: S0016\u20135085(16)00177\u20133"},{"key":"10.3238\/arztebl.2018.0222_ref2","doi-asserted-by":"crossref","unstructured":"Ford AC, Marwaha A, Lim A, Moayyedi P: What is the prevalence of clinically significant endoscopic findings in subjects with dyspepsia? Systematic review and meta-analysis. Clin Gastroenterol Hepatol 2010; 8: 830\u20137","DOI":"10.1016\/j.cgh.2010.05.031"},{"key":"10.3238\/arztebl.2018.0222_ref3","unstructured":"Madisch A, Hotz J: Gesundheits\u00f6konomische Aspekte der funktionellen Dyspepsie und des Reizdarmsyndroms. Gesundh \u00f6kon Qual manag 2000; 5: 32\u20135."},{"key":"10.3238\/arztebl.2018.0222_ref4","doi-asserted-by":"crossref","unstructured":"Moayyedi PM, Lacy BE, Andrews CN, Enns RA, Howden CW, Vakil N: ACG and CAG. Clinical Guideline: Management of dyspepsia. Am J Gastroenterol 2017; 112: 988\u20131013","DOI":"10.1038\/ajg.2017.154"},{"key":"10.3238\/arztebl.2018.0222_ref5","doi-asserted-by":"crossref","unstructured":"Talley NJ, Ford AC. Functional dyspepsia. N Engl J Med 2015; 373: 1853\u201363","DOI":"10.1056\/NEJMra1501505"},{"key":"10.3238\/arztebl.2018.0222_ref6","doi-asserted-by":"crossref","unstructured":"Talley NJ, Walker MM, Holtmann G: Functional dyspepsia. Curr Opin Gastroenterol 2016; 32: 467\u201373","DOI":"10.1097\/MOG.0000000000000306"},{"key":"10.3238\/arztebl.2018.0222_ref7","unstructured":"GFK Marktforschung N\u00fcrnberg: Die 100 wichtigsten Krankheiten. Woran die Deutschen nach Selbsteinsch\u00e4tzung leiden. Apotheken-Umschau 1\/2006."},{"key":"10.3238\/arztebl.2018.0222_ref8","unstructured":"Eggleston A, Farup C, Meier R: The domestic\/international gastroenterology surveillance study (DIGEST): design, subjects and methods. Scand J Gastroenterol 1999; 231(Suppl): 9\u201314."},{"key":"10.3238\/arztebl.2018.0222_ref9","unstructured":"Lacy BE, Weiser KT, Kennedy AT, Crowel MD, Talley NJ: Functional dyspepsia: the economic impact to patients. Aliment Pharmacol Ther 2011; 33: 561\u201371."},{"key":"10.3238\/arztebl.2018.0222_ref10","doi-asserted-by":"crossref","unstructured":"Talley NJ: Functional dyspepsia: Advances in diagnosis and therapy. Gut and Liver 2017; 3: 349\u201357","DOI":"10.5009\/gnl16055"},{"key":"10.3238\/arztebl.2018.0222_ref11","doi-asserted-by":"crossref","unstructured":"Oustamanolakis, P, Tack J: Dyspepsia: organic versus functional. J Clin Gastroenterol 2012; 46, 175\u201390","DOI":"10.1097\/MCG.0b013e318241b335"},{"key":"10.3238\/arztebl.2018.0222_ref12","doi-asserted-by":"crossref","unstructured":"Schemann M: Reizdarm und Reizmagen-Pathopysiologie und Biomarker. Gastroenterologe 2017; 2: 114\u201329","DOI":"10.1007\/s11377-017-0143-7"},{"key":"10.3238\/arztebl.2018.0222_ref13","doi-asserted-by":"crossref","unstructured":"Enck P, Azpiroz F, Boeckxstaens G, et al.: Functional dyspepsia. Nat Rev Dis Primers 2017; 3: 17081","DOI":"10.1038\/nrdp.2017.81"},{"key":"10.3238\/arztebl.2018.0222_ref14","doi-asserted-by":"crossref","unstructured":"Bortolotti M, Bolondi L, Santi V, Sarti P, Brunelli F, Barbara L: Patterns of gastric emptying in dysmotility-like dyspepsia. Scand J Gastroenterol 1995; 30, 408\u201310","DOI":"10.3109\/00365529509093299"},{"key":"10.3238\/arztebl.2018.0222_ref15","doi-asserted-by":"crossref","unstructured":"Kim DY, Delgado-Aros S, Camilleri M, et al.: Noninvasive measurement of gastric accommodation in patients with idiopathic nonulcer dyspepsia. Am J Gastroenterol 2001; 96: 3099\u2013105","DOI":"10.1111\/j.1572-0241.2001.05264.x"},{"key":"10.3238\/arztebl.2018.0222_ref16","doi-asserted-by":"crossref","unstructured":"Coffin B, Azpiroz F, Guarner F, Malagelada JR: Selective gastric hypersensitivity and reflex hyporeactivity in functional dyspepsia. Gastroenterol 1994; 107, 1345\u201351","DOI":"10.1016\/0016-5085(94)90536-3"},{"key":"10.3238\/arztebl.2018.0222_ref17","doi-asserted-by":"crossref","unstructured":"Troncon LE, Thompson DG, Ahluwalia, NK, Barlow J, Heggie L: Relations between upper abdominal symptoms and gastric distension abnormalities in dysmotility like functional dyspepsia and after vagotomy. Gut 1995; 37: 17\u201322","DOI":"10.1136\/gut.37.1.17"},{"key":"10.3238\/arztebl.2018.0222_ref18","doi-asserted-by":"crossref","unstructured":"Mertz H, Fullerton S, Naliboff B, Mayer EA: Symptoms and visceral perception in severe functional and organic dyspepsia. Gut 1998; 42, 814\u201322","DOI":"10.1136\/gut.42.6.814"},{"key":"10.3238\/arztebl.2018.0222_ref19","doi-asserted-by":"crossref","unstructured":"Simr\u00e9n M, T\u00f6rnblom H, Palsson OS, et al.: Visceral hypersensitivity is associated with GI symptom severity in functional GI disorders: consistent findings from five different patient cohorts. Gut 2018; 67: 255\u201362","DOI":"10.1136\/gutjnl-2016-312361"},{"key":"10.3238\/arztebl.2018.0222_ref20","doi-asserted-by":"crossref","unstructured":"Mearin F, Cucala M, Azpiroz F, Malagelada JR: The origin of symptoms on the brain-gut axis in functional dyspepsia. Gastroenterol 1991; 101: 999\u20131006","DOI":"10.1016\/0016-5085(91)90726-2"},{"key":"10.3238\/arztebl.2018.0222_ref21","doi-asserted-by":"crossref","unstructured":"Grundy D, Al-Chaer ED, Aziz Q, et al.: Fundamentals of neurogastroenterology: basic science. Gastroenterol 2006; 130: 1391\u2013411","DOI":"10.1053\/j.gastro.2005.11.060"},{"key":"10.3238\/arztebl.2018.0222_ref22","doi-asserted-by":"crossref","unstructured":"Bouin M, Lupien F, Riberdy-Poitras M, Poitras P: Tolerance to gastric distension in patients with functional dyspepsia: modulation by a cholinergic and nitrergic method. Eur J Gastroenterol Hepatol 2006; 18: 63\u20138","DOI":"10.1097\/00042737-200601000-00011"},{"key":"10.3238\/arztebl.2018.0222_ref23","doi-asserted-by":"crossref","unstructured":"Lee KJ, Demarchi B, Demedts I, Sifrim D, Raeymaekers P, Tack J.A: Pilot study on duodenal acid exposure and its relationship to symptoms in functional dyspepsia with prominent nausea. Am J Gastroenterol 2004; 99: 1765\u201373","DOI":"10.1111\/j.1572-0241.2004.30822.x"},{"key":"10.3238\/arztebl.2018.0222_ref24","doi-asserted-by":"crossref","unstructured":"Samsom M, Verhagen MA, vanBerge Henegouwen GP, Smout AJ: Abnormal clearance of exogenous acid and increased acid sensitivity of the proximal duodenum in dyspeptic patients. Gastroenterol 1999; 116: 515\u201320","DOI":"10.1016\/S0016-5085(99)70171-X"},{"key":"10.3238\/arztebl.2018.0222_ref25","doi-asserted-by":"crossref","unstructured":"Hammer J, F\u00fchrer M, Pipal L, Matiasek J: Hypersensitivity for capsaicin in patients with functional dyspepsia. Neurogastroenterol Motil 2008; 20: 125\u201333","DOI":"10.1111\/j.1365-2982.2007.00997.x"},{"key":"10.3238\/arztebl.2018.0222_ref26","doi-asserted-by":"crossref","unstructured":"Feinle-Bisset C: Upper gastrointestinal sensitivity to meal-related signals in adult humans \u2013 relevance to appetite regulation and gut symptoms in health, obesity and functional dyspepsia. Physiol Behav\u00a02016; 62: 69\u201382","DOI":"10.1016\/j.physbeh.2016.03.021"},{"key":"10.3238\/arztebl.2018.0222_ref27","doi-asserted-by":"crossref","unstructured":"Enck P, Aziz Q, Barbara G, et al.: Irritable bowel syndrome. Nat Rev Dis Primers. 2016; 2: 16014","DOI":"10.1038\/nrdp.2016.14"},{"key":"10.3238\/arztebl.2018.0222_ref28","doi-asserted-by":"crossref","unstructured":"Delaney B, Ford AC, Forman D, Moayyedi P, Qume M: Initial management strategies for dyspepsia. Cochrane Database Syst Rev 2005; 19; CD00196","DOI":"10.1002\/14651858.CD001961.pub2"},{"key":"10.3238\/arztebl.2018.0222_ref29","doi-asserted-by":"crossref","unstructured":"Labenz J, Koop H. [Gastro-oesophageal reflux disease \u2013 how to manage if PPI are not sufficiently effective, not tolerated, or not wished?]. Dtsch Med Wochenschr 2017; 142: 356\u201366","DOI":"10.1055\/s-0042-121021"},{"key":"10.3238\/arztebl.2018.0222_ref30","doi-asserted-by":"crossref","unstructured":"Van Oudenhove L, Aziz Q: The role of psychosocial factors and psychiatric disorders in functional dyspepsia. Nat Rev Gastroenterol Hepatol 2013; 10: 158\u201367","DOI":"10.1038\/nrgastro.2013.10"},{"key":"10.3238\/arztebl.2018.0222_ref31","doi-asserted-by":"crossref","unstructured":"Oudenhove L, Walker MM, Holtmann G, Koloski NA, Talley NJ: Mood and anxiety disorders precede development of functional gastrointestinal disorders in patients but not in the population. Clin Gastroenterol Hepatol 2017; 15: 1014\u201320","DOI":"10.1016\/j.cgh.2016.12.032"},{"key":"10.3238\/arztebl.2018.0222_ref32","doi-asserted-by":"crossref","unstructured":"Pinto-Sanchez MI, Ford AC, Avila CA, et al.: Anxiety and depression increase in a stepwise manner in parallel with multiple FGIDs and symptom severity and frequency. Am J Gastroenterol 2015; 110: 1038\u201348","DOI":"10.1038\/ajg.2015.128"},{"key":"10.3238\/arztebl.2018.0222_ref33","doi-asserted-by":"crossref","unstructured":"Fischbach W, Malfertheiner P, Lynen Jansen P, et al.: S2k-Leitlinie Helicobacter pylori und gastroduodenale Ulkuskrankheit. Z Gastroenterol 2016; 54: 327\u201363","DOI":"10.1055\/s-0042-102967"},{"key":"10.3238\/arztebl.2018.0222_ref34","doi-asserted-by":"crossref","unstructured":"Madisch A, Miehlke S, Labenz J: Management of functional dyspepsia: Unsolved problems and new perspectives. World J Gastroenterol 2005; 11: 6577\u201381","DOI":"10.3748\/wjg.v11.i42.6577"},{"key":"10.3238\/arztebl.2018.0222_ref35","doi-asserted-by":"crossref","unstructured":"Wang WH, Huang JQ, Zheng GF, et al.: Effects of proton-pump inhibitors on functional dyspepsia: a meta-analysis of randomized placebo-controlled trials. Clin Gastroenterol Hepatol. 2007; 5: 178\u201385","DOI":"10.1016\/j.cgh.2006.09.012"},{"key":"10.3238\/arztebl.2018.0222_ref36","doi-asserted-by":"crossref","unstructured":"M\u00f6ssner J: The indications, applications, and risks of proton pump inhibitors. Dtsch Arztebl Int 2016; 113: 477\u201383","DOI":"10.3238\/arztebl.2016.0477"},{"key":"10.3238\/arztebl.2018.0222_ref37","doi-asserted-by":"crossref","unstructured":"Zhao B, Zhao J, Cheng WF, et al.: Efficacy of Helicobacter pylori eradication therapy on functional dyspepsia: a meta-analysis of randomized controlled studies with 12-month follow-up. J Clin Gastroenterol 2014; 48: 241\u20137","DOI":"10.1097\/MCG.0b013e31829f2e25"},{"key":"10.3238\/arztebl.2018.0222_ref38","doi-asserted-by":"crossref","unstructured":"Sugano K, Tack J, Kuipers EJ, et al.: Kyoto global consensus report on Helicobacter pylori gastritis. Gut 2015; 64: 1353\u201367","DOI":"10.1136\/gutjnl-2015-309252"},{"key":"10.3238\/arztebl.2018.0222_ref39","doi-asserted-by":"crossref","unstructured":"Melzer J, Rosch W, Reichling J, Brignoli R, Saller R: Meta-analysis: phytotherapy of functional dyspepsia with the herbal drug preparation STW 5. Aliment Pharmacol Ther 2004; 20: 1279\u201387","DOI":"10.1111\/j.1365-2036.2004.02275.x"},{"key":"10.3238\/arztebl.2018.0222_ref40","doi-asserted-by":"crossref","unstructured":"Hohenester B, R\u00fchl A, Kelber O, Schemann M: The herbal preparation STW5 has potent and region-specific effects on gastric motility. Neurogastroenterol Motil 2004; 16: 765\u201373","DOI":"10.1111\/j.1365-2982.2004.00548.x"},{"key":"10.3238\/arztebl.2018.0222_ref41","doi-asserted-by":"crossref","unstructured":"Madisch A, Vinson BR, Abdel-Aziz H, et al.: Modulation of gastrointestinal motility beyond metoclopramide and domperidone: Pharmacological and clinical evidence for phytotherapy in functional gastrointestinal disorders. Wien Med Wochenschr 2017; 167: 160\u20138","DOI":"10.1007\/s10354-017-0557-3"},{"key":"10.3238\/arztebl.2018.0222_ref42","doi-asserted-by":"crossref","unstructured":"Madisch A, Heydenreich CJ, Wieland V et al.:Treatment of functional dyspepsia with a fixed peppermint oil and caraway oil combination preparation as compared to cisapride. A multicenter, reference-controlled double-blind equivalence study. Drug Res 1999; 49 (II): 925\u201332.","DOI":"10.1055\/s-0031-1300528"},{"key":"10.3238\/arztebl.2018.0222_ref43","doi-asserted-by":"crossref","unstructured":"von Arnim U, Peitz U, Vinson B, Gundermann KJ, Malfertheiner P: STW 5, a phytopharmacon for patients with functional dyspepsia: results of a multicenter, placebo-controlled double-blind study. Am J Gastroenterol 2007; 102: 1268\u20137","DOI":"10.1111\/j.1572-0241.2006.01183.x"},{"key":"10.3238\/arztebl.2018.0222_ref44","unstructured":"Brilmayer H, Faust W, Schliemann J: Non-ulcer dyspepsia. Beschwerden und deren medikament\u00f6se Beeinflussung. in: Maiwald et al., Periodica Medica: Enzynorm forte \u2013 funktionelle Bedeutung und klinische Wirksamkeit. Reinbek: Einhorn Presse Verlag, 1988:71\u201385."},{"key":"10.3238\/arztebl.2018.0222_ref45","doi-asserted-by":"crossref","unstructured":"Ford AC, Luthra P, Tack J, et al.: Efficacy of psychotropic drugs in functional dyspepsia: systematic review and meta-analysis. Gut 2017; 66: 410\u2013420","DOI":"10.1136\/gutjnl-2015-310721"},{"key":"10.3238\/arztebl.2018.0222_ref46","doi-asserted-by":"crossref","unstructured":"Talley NJ, Locke GR, Saito YA, et al.: Effect of amitriptyline and escitalopram on functional dyspepsia: A multicenter, randomized controlled study. Gastroenterology 2015; 149: 340\u20139","DOI":"10.1053\/j.gastro.2015.04.020"},{"key":"10.3238\/arztebl.2018.0222_ref47","doi-asserted-by":"crossref","unstructured":"Orive M, Barrio I, Orive VM, et al.: A randomized controlled trial of a\u00a010 week group psychotherapeutic treatment added to standard medical treatment in patients with functional dyspepsia. J Psychosom Res 2015; 78: 563","DOI":"10.1016\/j.jpsychores.2015.03.003"},{"key":"10.3238\/arztebl.2018.0222_ref48","doi-asserted-by":"crossref","unstructured":"Mearin F, Rodrigo L, P\u00e9rez-Mota A, et al.: Levosulpiride and cisapride in the treatment of dysmotility-like functional dyspepsia: a randomized, double-masked trial. Clin Gastroenterol Hepatol 2004; 2: 301\u20138","DOI":"10.1016\/S1542-3565(04)00059-X"},{"key":"10.3238\/arztebl.2018.0222_ref49","doi-asserted-by":"crossref","unstructured":"Xiao G, Xie X, Fan J, et al.: Efficacy and safety of acotiamide for the treatment of functional dyspepsia: systematic review and meta-analysis. Scientific World Journal 2014: 541950","DOI":"10.1155\/2014\/541950"},{"key":"10.3238\/arztebl.2018.0222_ref50","doi-asserted-by":"crossref","unstructured":"Holtmann G, Talley NJ, Liebregts T, Adam B, Parow C: A placebo-controlled trial of itopride in functional dyspepsia. N Engl J Med 2006; 354: 832\u201340","DOI":"10.1056\/NEJMoa052639"}],"container-title":["Deutsches \u00c4rzteblatt international"],"original-title":[],"link":[{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.2018.0222","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T09:33:51Z","timestamp":1719912831000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.2018.0222"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,30]]},"references-count":50,"URL":"https:\/\/doi.org\/10.3238\/arztebl.2018.0222","relation":{},"ISSN":["1866-0452"],"issn-type":[{"value":"1866-0452","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,30]]}}}